SIL-204 administered in an extended release formulation reduced tumor growth by ~50% after 30 days, with ~50% of tumors ...

Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue ...

Pluristyx has developed a clinical-grade manufacturing process for using a licensed Mad7 gene editing technology to block Human Leukocyte Antigen (HLA) markers expression. Humacyte is optimizing a ...

Cystic fibrosis (CF) is a life-threatening genetic disease affecting multiple organ systems, with pancreatic dysfunction representing a critical and often overlooked complication.

The model is the first of its kind to use multiple types of imaging and language-based data to assess a cancer patient's ...

“A facelift for the Model 3 comes just in the nick of time to nudge it back ahead of rivals” There can’t be anyone who doesn’t know what a Tesla is: it’s incredible how the startup ...

Exclusion criteria were history of PC, pancreatic cyst, IgG4 disease ... and multivariable Cox regression model was employed to derive adjusted HR (aHR). Propensity-score (PS) matching was used as ...

Elraglusib is aimed at treating pancreatic ductal adenocarcinoma. Credit: Jo Panuwat D/Shutterstock. Actuate Therapeutics has gained orphan medicinal product designation (OMPD) from the European ...

For some reason, the immune system mistakenly attacks and destroys insulin-producing beta cells in the pancreas. Genes may play a role in some people. It’s also possible that a virus sets off an ...

An enzyme called MICAL2 promotes tumor growth and metastasis in the most common form of pancreatic cancer, according to a new study. Pancreatic cancer kills 50,000 people each year, according to ...

Our spy photographer spotted a camouflaged 2025 Model Y (nicknamed Juniper) testing on public roads in Europe. KGP Photography While the front and rear bumpers are both wearing disguises ...